---
category: news
title: "Alzheimer’s disease: 'Encouraging' data suggest new drug slows cognitive decline"
excerpt: "Phase 3 clinical trial results shared in a press release suggest a new drug called lecanemab helps slow the cognitive decline rate in Alzheimer’s patients by 27% after 18 months of treatment."
publishedDateTime: 2022-10-06T00:00:00Z
originalUrl: "https://www.medicalnewstoday.com/articles/alzheimers-disease-encouraging-data-suggest-new-drug-slows-cognitive-decline"
webUrl: "https://www.medicalnewstoday.com/articles/alzheimers-disease-encouraging-data-suggest-new-drug-slows-cognitive-decline"
type: article

provider:
  name: Medical News Today
  domain: medicalnewstoday.com

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://post.medicalnewstoday.com/wp-content/uploads/sites/3/2022/10/alzheimers_drug_study_positive_results_732x549_thumb.jpg"
    width: 732
    height: 549
    isCached: true

secured: "sPJeeDnijo0NLkGbNFy5UmZw3K0KD5HckMgPUCkUh2eoIcu7IpAwFcQ+ex2ScrH7nwqZ/GXI96xBCtiMDLty3QkLoRFuycnA2JRg6fK2GKutisUYe2VkkgCxCusMGYCuzUBevorOYU579z2prOXD0erNu1LJ8K/BjAWKw+uDiiGIJA+bJ+RaYY94gO6h/zhHsllUi65vP0ANvA3CqsFCpePSjbjcJjGER9YsmxVm0Z2SXr2bY37RINLdNmENm/xvBx6tmD4cJqA+l2qnCC3BaplqmC0tdoeGZekD632sNVtJUyWABuOI7qqPWd/7olZ8QYb5ilgfjKgKaZH5lBdG4kfrpS3KkAY07aMDIrXgKc0=;ZMsq26RnbeXN/t6sMQu5BA=="
---

